Logo

American Heart Association

  10
  0


Final ID: MP425

GP73 Associates Causally with Incident Heart Failure through Insulin Resistance in Community-Dwelling Adults: The ARIC Study

Abstract Body (Do not enter title and authors here): Background: High fat diet induces GP73 secretion from the liver, heart and adipose tissue. GP73 promotes metabolic dysfunction and insulin resistance in preclinical studies, but whether GP73’s metabolic effects mediate its association with incident HF remains unclear.
Objective: We sought to determine whether metabolic dysfunction mediates the association between GP73 and incident HF in community-dwelling adults.
Methods: We performed causal mediation analyses within the ongoing, longitudinal, observational, Atherosclerosis Risk in Communities (ARIC) study. GP73 levels were measured at ARIC Visit 2 using an aptamer-based assay validated against mass spectrometry (Pearson R = 0.84). The potential metabolic mediators were assessed at Visit 4 (median of 6 years after Visit 2) and included diabetes, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), the five components of the metabolic syndrome and urine albumin-to-creatinine ratio > 30 mg/g. Incident heart failure hospitalizations after Visit 4 were identified through previously reported ARIC event surveillance methods. Causal mediation analysis used the Imai-Keele-Tingley counterfactual framework. We tested the potential causal effects of GP73 on metabolic risk factors using Mendelian randomization.
Results: The ARIC cohort mean age was 57 years (66% women and 20% Black). ARIC participants with GP73 above the median were more likely to have diabetes or the metabolic syndrome and had higher fasting plasma glucose, higher HOMA-IR and greater waist circumference. Metabolic risk factors that significantly mediated the association between GP73 and incident HF included HOMA-IR (33%; P=0.04), waist circumference (23%; P<0.001), systolic blood pressure (9%; P<0.001), urine albumin-to-creatinine ratio > 30 mg/g (7%; P<0.001) and HDL cholesterol (3%; P<0.001). Mendelian randomization analysis provided evidence of causal effects of GP73 on fasting pro-insulin levels, HbA1c levels, type 2 diabetes and heart failure. Reverse mediation analysis with GP73 as the mediator and reverse Mendelian randomization with GP73 as the outcome did not support causal effects of metabolic risk factors on GP73 levels.
Conclusions: GP73 associates with the development of incident heart failure in community-dwelling adults through its effects on insulin resistance, adiposity and vascular dysfunction.
  • Buckley, Leo  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Grams, Morgan  ( New York University , New York , New York , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Claggett, Brian  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Matsushita, Kunihiro  ( Johns Hopkins Bloomberg School of Public Health , Baltimore , Maryland , United States )
  • Lutsey, Pamela  ( University of Minnesota , Minneapolis , Minnesota , United States )
  • Lennep, Brandon  ( University of Mississippi , Jackson , Massachusetts , United States )
  • Bancks, Michael  ( Wake Forest University School of Medicine , Winston-Salem , North Carolina , United States )
  • Chang, Patricia  ( University of North Carolina , Chapel Hill , North Carolina , United States )
  • Ballantyne, Christie  ( Baylor College of Medicine , Houston , Texas , United States )
  • Hoogeveen, Ron  ( Baylor College of Medicine , Houston , Texas , United States )
  • Author Disclosures:
    Leo Buckley: DO NOT have relevant financial relationships | Morgan Grams: DO NOT have relevant financial relationships | Amil Shah: DO NOT have relevant financial relationships | Brian Claggett: No Answer | Kunihiro Matsushita: No Answer | Pamela Lutsey: DO NOT have relevant financial relationships | Brandon Lennep: DO NOT have relevant financial relationships | Michael Bancks: No Answer | Patricia Chang: DO NOT have relevant financial relationships | Christie Ballantyne: No Answer | Ron Hoogeveen: DO have relevant financial relationships ; Consultant:Denka Seiken:Active (exists now) ; Research Funding (PI or named investigator):Denka Seiken:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Novel Mechanistic Pathways Underlying Cardiometabolic Risk

Saturday, 11/08/2025 , 09:15AM - 10:25AM

Moderated Digital Poster Session

More abstracts on this topic:
A Novel Approach to Manage Hypercholesterolemia: The Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) Program

Djousse Luc, Leesch Tharen, Pena David, Gaziano Michael, Ward Rachel, Wellman Helen, Yel Nedim, Santos Abigail, Delgrande Jen, Fink Abigail, Colson Kristin, Pan Eddie

A Contemporary Machine Learning-Based Risk Stratification for Mortality and Hospitalization in Heart Failure with Preserved Ejection Fraction Using Multimodal Real-World Data

Fudim Marat, Weerts Jerremy, Patel Manesh, Balu Suresh, Hintze Bradley, Torres Francisco, Micsinai Balan Mariann, Rigolli Marzia, Kessler Paul, Touzot Maxime, Lund Lars, Van Empel Vanessa, Pradhan Aruna, Butler Javed, Zehnder Tobias, Sauty Benoit, Esposito Christian, Balazard Félix, Mayer Imke, Hallal Mohammad, Loiseau Nicolas

More abstracts from these authors:
Pulmonary Arterial Pruning is Associated with Increased Pulmonary Pressure and Worse Left Ventricular Systolic and Diastolic Function in Late Life

Dewanjee Aditya, Lamberson Victoria, Yang Yimin, Claggett Brian, Matsushita Kunihiro, Blaha Michael, Washko George, San Jose Estepar Raul, Shah Amil

Large Scale Proteomics Identifies Circulating Biomarkers Relating Atrial Fibrillation to Heart Failure: the Atherosclerosis Risk in Communities Study

Giugni Fernando, Shah Amil, Lamberson Victoria, Yang Yimin, Chen Lin, Matsushita Kunihiro, Hoogeveen Ron, Ballantyne Christie, Coresh Josef, Yu Bing

You have to be authorized to contact abstract author. Please, Login
Not Available